Selvita S.A. (WSE:SLV)
Poland · Delayed Price · Currency is PLN 41.30
-0.30 (-0.72%)
Nov 14, 2025, 5:00 PM CET
Selvita Market Cap
Selvita has a market cap or net worth of 758.08 million as of November 14, 2025. Its market cap has decreased by -25.45% in one year.
Market Cap
758.08M
Enterprise Value
948.09M
Revenue
373.90M
Ranking
n/a
PE Ratio
1,630.28
Stock Price
41.30
Market Cap Chart
Since October 16, 2019, Selvita's market cap has increased from 335.40M to 758.08M, an increase of 126.03%. That is a compound annual growth rate of 14.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 758.08M | -16.57% |
| Dec 30, 2024 | 908.60M | -15.38% |
| Dec 29, 2023 | 1.07B | -29.43% |
| Dec 30, 2022 | 1.52B | 1.10% |
| Dec 30, 2021 | 1.51B | 66.33% |
| Dec 30, 2020 | 904.92M | 141.11% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.10B |
| NEUCA | 3.54B |
| Synektik Spólka Akcyjna | 2.22B |
| Voxel | 1.63B |
| Celon Pharma | 1.15B |
| Centrum Medyczne ENEL-MED | 523.19M |
| Bioceltix | 462.41M |
| Ryvu Therapeutics | 453.38M |